Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Research Foundation, interviewed Boris Sepesi, MD, a thoracic surgeon at MD Anderson Cancer Center. The conversation covers:
- Preparations for treating COVID-19 patients and COVID-19 vaccine development teams.
- Dr. Sepesi’s upcoming Phase 1 clinical trial with Dr. Patrick Forde.
MD Anderson Cancer Center:
- Treatment: Available for some treatment.
- Clinical trials: Paused except for clinical trials deemed essential.
- Surgery: Most are delayed, but they are still treating patients with neoadjuvant therapy of pemetrexed + platinum based chemotherapy.
Watch MesoTV
This MesoTV interview was made possible by the support of sponsors who have stepped up during this difficult time to ensure that we can continue serving the mesothelioma community. Please take note of them at the beginning of the video: Novocure; Belluck & Fox, LLP; University of Pittsburgh Medical Center (UPMC); Vogelzang Law; and Merrill Lynch.
Get notified when our next video is published by clicking the red “Subscribe” button below.
MesoTV is the Mesothelioma Applied Research Foundation’s recorded video series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv.
